Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer

Epidermal growth factor receptor (EGFR) is extensively expressed in head and neck cancer. However, EGFR-targeted therapy has only modest efficacy in head and neck cancer, through mechanisms that are not fully understood. Here, we found that inhibition of EGFR by erlotinib stimulated phosphorylation...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, You, Shuo, Hu, Zhongliang, Chen, Zhuo G., Sica, Gabriel L., Khuri, Fadlo R., Curran, Walter J., Shin, Dong M., Deng, Xingming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760825/
https://www.ncbi.nlm.nih.gov/pubmed/24019973
http://dx.doi.org/10.1371/journal.pone.0074670

Ejemplares similares

Ejemplares similares